{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:58:14Z","timestamp":1762322294856,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI17\/00251"],"award-info":[{"award-number":["PI17\/00251"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijantimicag.2025.107477","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:15:20Z","timestamp":1740744920000},"page":"107477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacodynamic interaction of apotransferrin and anti-pseudomonal antibiotics against extensively drug-resistant Pseudomonas aeruginosa in a dynamic PK\/PD model"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5991-6804","authenticated-orcid":false,"given":"Mar\u00eda M","family":"Montero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4315-9794","authenticated-orcid":false,"given":"Sandra","family":"Domene-Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Prim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"L\u00f3pez-Causap\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Echeverria-Esnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9562-514X","authenticated-orcid":false,"given":"Luisa","family":"Sorl\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-585X","authenticated-orcid":false,"given":"Eduardo","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-5459","authenticated-orcid":false,"given":"Juan P.","family":"Horcajada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107477_sbref0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2011.01.001","article-title":"Creeping baselines and adaptive resistance to antibiotics","volume":"14","author":"Fern\u00e1ndez","year":"2011","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107477_sbref0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107477_sbref0003","doi-asserted-by":"crossref","DOI":"10.1186\/2047-2994-3-32","article-title":"Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"3","author":"Nathwani","year":"2014","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107477_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","article-title":"The increasing threat of Pseudomonas aeruginosa high-risk clones","volume":"21-22","author":"Oliver","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0006","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnology Advances"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0007","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0008","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","article-title":"The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update","volume":"81","author":"Reynolds","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0009","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/cid\/ciad758","article-title":"The real crisis in antimicrobial resistance: failure to anticipate and respond","volume":"78","author":"Bonomo","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0010","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1093\/jac\/dkz225","article-title":"Adjunctive transferrin to reduce the emergence of antibiotic resistance in gram-negative bacteria","volume":"74","author":"Luna","year":"2019","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107477_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00112-19","article-title":"Apotransferrin in combination with ciprofloxacin slows bacterial replication, prevents resistance amplification, and increases antimicrobial regimen effect","volume":"63","author":"Ambrose","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0012","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chom.2013.04.010","article-title":"Iron in infection and immunity","volume":"13","author":"Cassat","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0013","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biotechadv.2010.11.007","article-title":"Recombinant human transferrin: beyond iron binding and transport","volume":"29","author":"Brandsma","year":"2011","journal-title":"Biotechnol Adv"},{"issue":"2","key":"10.1016\/j.ijantimicag.2025.107477_bib0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/infdis\/jiu049","article-title":"Transferrin iron starvation therapy for lethal bacterial and fungal infections","volume":"210","author":"Lin","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0928-8244(03)00109-3","article-title":"Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron","volume":"37","author":"von Bonsdorff","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0016","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1467-7652.2010.00499.x","article-title":"Plant-derived recombinant human serum transferrin demonstrates multiple functions","volume":"8","author":"Brandsma","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"11","key":"10.1016\/j.ijantimicag.2025.107477_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01589-17","article-title":"Genomics and susceptibility profiles of extensively drug-resistant pseudomonas aeruginosa isolates from Spain","volume":"61","author":"del Barrio-Tofi\u00f1o","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0018","unstructured":"M100 Performance Standards for Antimicrobial Susceptibility Testing A CLSI supplement for global application. 2020 [accessed 28.06.21]. www.clsi.org."},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0019","unstructured":"Committee E. European Committee on Antimicrobial Susceptibility Testing. 2022 [accessed 05.10.23]. EUCAST: Clinical breakpoints and dosing of antibiotics. https:\/\/www.eucast.org\/clinical_breakpoints"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jgar.2019.04.012","article-title":"Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones","volume":"18","author":"Montero","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1001043","article-title":"A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design","volume":"7","author":"Tam","year":"2011","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107477_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02542-19","article-title":"Efficacy of ceftolozane-tazobactam in combination with colistin against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones, in an in vitro pharmacodynamic model","volume":"64","author":"Montero","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"year":"2014","series-title":"FDA, Zerbaxa (Ceftolozane\/Tazobactam) For Injection Package Insert","key":"10.1016\/j.ijantimicag.2025.107477_bib0023"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0024","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1128\/AAC.00461-13","article-title":"Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model","volume":"57","author":"Vanscoy","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0025","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/AAC.03639-14","article-title":"In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae","volume":"59","author":"Lim","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0026","unstructured":"American Society for Microbiology. Synergy and antagonism. [accessed 23.10.24]. https:\/\/journals.asm.org\/writing-your-paper#abbreviations"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0027","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","article-title":"Ceftolozane\/tazobactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli","volume":"74","author":"Zhanel","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0028","unstructured":"Grasso S., Meinardi G., de Carneri I., Tamassia V. New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity [Internet]. Antimicrob Agents Chemother. 1978. [accessed 10. 12. 24]. Available from: https:\/\/journals.asm.org\/journal\/aac."},{"issue":"6","key":"10.1016\/j.ijantimicag.2025.107477_bib0029","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/chromsci\/bmw047","article-title":"Development of an HPLC method for the determination of Ceftolozane\/Tazobactam in biological and aqueous matrixes [Internet]","volume":"54","author":"Sutherland","year":"2016","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2141.2006.06273.x","article-title":"Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation","volume":"135","author":"Parkkinen","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ijantimicag.2025.107477_bib0031","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2141.2002.03836.x","article-title":"Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients","volume":"119","author":"Sahlstedt","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0032","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/AAC.01481-13","article-title":"Biological markers of Pseudomonas aeruginosa epidemic high-risk clones","volume":"57","author":"Mulet","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0033","unstructured":"Grasso S, Meinardi G, de Carneri I, Tamassia V. New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity [Internet]. Antimicrob Agents Chemother. 1978. [accessed 12.12.2023]. Available from: https:\/\/journals.asm.org\/journal\/aac."},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0034","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/jac\/dkz030","article-title":"High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial","volume":"74","author":"P\u00e9rez","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0035","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/AAC.01802-13","article-title":"Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. hospitals (2011-2012)","volume":"57","author":"Farrell","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.ijantimicag.2025.107477_bib0036","first-page":"4474","article-title":"The neglected intrinsic resistome of bacterial pathogens","volume":"52","author":"Fajardo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0037","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/AAC.02462-13","article-title":"Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC","volume":"58","author":"Cabot","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0038","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3201\/eid1808.111234","article-title":"VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain","volume":"18","author":"Viedma","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107477_bib0039","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/AAC.02151-13","article-title":"Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactam","volume":"58","author":"Wooley","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:42:30Z","timestamp":1762321350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0924857925000342"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107477","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic interaction of apotransferrin and anti-pseudomonal antibiotics against extensively drug-resistant Pseudomonas aeruginosa in a dynamic PK\/PD model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107477"}}